Hansoh Pharmaceutical Group Company Limited (HNSPF)

HNSPF Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Feb 10, 2026	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	29,397	13,202	11,951	11,269	14,430	28,704
Market Cap Growth	123.98%	10.47%	6.05%	-21.91%	-49.73%	49.13%
Enterprise Value	25,611	9,968	9,325	8,742	12,233	26,321
Last Close Price	4.46	2.13	1.83	-	-	-
PE Ratio	44.05	22.04	25.86	30.08	33.79	72.95
PS Ratio	15.97	7.86	8.39	8.28	9.23	21.56
PB Ratio	6.77	3.36	3.29	3.43	4.58	10.48
P/TBV Ratio	6.84	3.39	3.31	3.44	4.58	10.49
P/FCF Ratio	46.88	26.47	29.25	31.49	43.30	194.63
P/OCF Ratio	44.01	24.95	27.19	28.35	35.57	78.39
EV/Sales Ratio	13.85	5.93	6.54	6.43	7.82	19.77
EV/EBITDA Ratio	37.75	17.01	21.86	20.57	25.20	57.49
EV/EBIT Ratio	40.98	18.65	24.68	23.13	27.55	61.97
EV/FCF Ratio	40.85	19.99	22.83	24.43	36.71	178.47
Debt / Equity Ratio	0.00	0.00	0.17	0.19	0.19	0.01
Debt / EBITDA Ratio	0.02	0.03	1.41	1.48	1.24	0.03
Debt / FCF Ratio	0.03	0.03	1.49	1.77	1.81	0.10
Asset Turnover	0.40	0.38	0.32	0.33	0.41	0.43
Inventory Turnover	1.93	1.82	2.02	2.03	2.46	2.25
Quick Ratio	8.31	9.90	4.11	9.64	7.50	6.30
Current Ratio	8.56	10.18	4.21	9.86	7.67	6.43
Return on Equity (ROE)	16.21%	16.05%	13.53%	12.11%	14.31%	16.62%
Return on Assets (ROA)	8.35%	7.54%	5.31%	5.70%	7.35%	8.59%
Return on Invested Capital (ROIC)	92.12%	63.34%	43.96%	44.33%	50.64%	170.48%
Return on Capital Employed (ROCE)	14.20%	13.50%	10.20%	9.50%	11.70%	15.30%
Earnings Yield	2.27%	4.54%	3.87%	3.32%	2.96%	1.37%
FCF Yield	2.13%	3.78%	3.42%	3.18%	2.31%	0.51%
Dividend Yield	-	2.03%	1.49%	-	-	-
Payout Ratio	38.87%	42.51%	19.90%	27.56%	14.04%	163.49%
Buyback Yield / Dilution	1.10%	1.16%	-1.52%	1.14%	-2.04%	-7.31%
Total Shareholder Return	1.10%	3.19%	-0.03%	1.14%	-2.04%	-7.31%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.